Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dexibuprofen manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

4 products found

dexibuprofen + paracetamol

Tablets 300 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #17708
This pharmaceutical company boasts over 75 years of experience in manufacturing, research & development, and global supply chain management for specialty pharmaceuticals. They have introduced over 100 unique molecules to the Indian market and hold prominent positions in 9 therapeutic segments across regions including the EU and North America. Their product portfolio is extensive, encompassing injectables, antibiotics, antifungals, antipyretics, cardiovascular medications, central nervous system drugs, corticosteroids, gastrointestinal treatments, and nutraceuticals. They also offer pediatric formulations and vaccines. The company emphasizes quality, affordability, and innovation, reflected in their GMP certifications and numerous product patents. Their key therapeutic areas include infectious diseases, pain management, cardiology, and pediatrics, with principal dosage forms ranging from oral solutions to injections.

Manufacturer usually replies in 4 days

dexibuprofen + paracetamol

Tablets 300 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18722
This pharmaceutical manufacturer boasts decades of experience in the industry, providing a broad range of affordable finished formulations, including prescription drugs, OTC medications, and supplements. They offer turnkey manufacturing, technology transfer, contract development and manufacturing services, as well as co-development and co-marketing options. Key therapy areas include chronic and acute therapies, OTCs, and complex formulations. Dosage forms include tablets, capsules, syrups, powders, liquids, injections, and ointments. They have obtained GMP approvals from regulatory bodies in the EU, North America, and other regions, demonstrating their commitment to quality and compliance. The company's global presence extends to key regions like North America, Asia, and Africa, solidifying their position as a trusted partner in the pharmaceutical industry.

Manufacturer usually replies in 7 days

dexibuprofen + paracetamol

Tablets 300 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18722
This pharmaceutical manufacturer boasts decades of experience in the industry, providing a broad range of affordable finished formulations, including prescription drugs, OTC medications, and supplements. They offer turnkey manufacturing, technology transfer, contract development and manufacturing services, as well as co-development and co-marketing options. Key therapy areas include chronic and acute therapies, OTCs, and complex formulations. Dosage forms include tablets, capsules, syrups, powders, liquids, injections, and ointments. They have obtained GMP approvals from regulatory bodies in the EU, North America, and other regions, demonstrating their commitment to quality and compliance. The company's global presence extends to key regions like North America, Asia, and Africa, solidifying their position as a trusted partner in the pharmaceutical industry.

Manufacturer usually replies in 7 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible